In order to unravel the potential molecular mechanisms responsible for ACTN1's role in the oncogenesis and drug resistance of HNSCC, we stratified HNSCC patients from the TCGA HNSCC cohort into ACTN1-high and ACTN1-low groups based on the median ACTN1 expression value. Here, ACTN1 is linked to head and neck squamous cell carcinoma.